Key facts
- This page summarizes Datuk Dr. Doris Wong Sing Ee's Form 4 filing for Bio Green Med Solution, Inc. (CYCC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 13 Nov 2025, 18:00.
Datuk Dr. Doris Wong Sing Ee - 12 Nov 2025 Form 4 Insider Report for Bio Green Med Solution, Inc. (CYCC)
- Reporting relationship
- Chief Executive Officer, Director, 10%+ Owner
- Issuer ticker
- CYCC
- Reported as of
- 12 Nov 2025
- Net transaction value
- +$420,249
- SEC form
- 4
- Accepted by SEC
- 13 Nov 2025, 18:00:01 UTC
- Prior SEC filing
- 28 Feb 2025
- Next SEC filing
- 01 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Datuk Dr. Doris Wong Sing Ee
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Datuk Dr. Doris Wong Sing Ee filed Form 4 for Bio Green Med Solution, Inc. (CYCC) on 13 Nov 2025.
Change
- Previous filing in this sequence was filed on 28 Feb 2025.
- Current net transaction value: +$420,249.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001892421
Primary reporting owner
Doris Wong Sing Ee
- Relationship
- Chief Executive Officer, Director, 10%+ Owner
- Address
- LEVEL 10, TOWER 11, AVENUE 5, NO. 8, JALAN KERINCHI, KUALA LUMPUR, MALAYSIA
- Signature
- /s/ Datuk Dr. Doris Wong Sing Ee
- Signature date
- 13 Nov 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BGMS
transaction
Common Stock
Award
- Transaction value
- $420,249
- Shares
- +300,178
- Change %
- +37%
- Price
- $1.40
- Shares after
- 1,111,131
- Date
- 12 Nov 2025
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
As adjusted for 1-for-16 reverse stock split on May 12, 2025 and 1-for-15 reverse stock split on July 7, 2025.